Ozcan, Zhai, Javed et al.: "PAX-2 is a helpful marker for diagnosing metastatic renal cell carcinoma: comparison with the renal cell carcinoma marker antigen and kidney-specific cadherin." in: Archives of pathology & laboratory medicine, Vol. 134, Issue 8, pp. 1121-9, 2010 (PubMed).
Monte, Webster, Neuberg et al.: "Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer." in: Cancer research, Vol. 70, Issue 15, pp. 6225-32, 2010 (PubMed).
Quick, Gokden, Sangoi et al.: "The distribution of PAX-2 immunoreactivity in the prostate gland, seminal vesicle, and ejaculatory duct: comparison with prostatic adenocarcinoma and discussion of prostatic zonal embryogenesis." in: Human pathology, Vol. 41, Issue 8, pp. 1145-9, 2010 (PubMed).
Rabban, McAlhany, Lerwill et al.: "PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma." in: The American journal of surgical pathology, Vol. 34, Issue 2, pp. 137-46, 2010 (PubMed).
Cordell, Darlay, Charoen et al.: "Whole-genome linkage and association scan in primary, nonsyndromic vesicoureteric reflux." in: Journal of the American Society of Nephrology : JASN, Vol. 21, Issue 1, pp. 113-23, 2010 (PubMed).